Charitable Donations
Alnylam Pharmaceuticals' Charitable Donations support science and research initiatives by charitable organizations, with a focus on ATTR amyloidosis, AHP, and PH1.
Funder: Alnylam Pharmaceuticals
Due Dates: Rolling (submit at least 45 days before funding is needed)
Funding Amounts: No published minimum or maximum; award size determined per request and may be less than requested.
Summary: Supports registered charitable organizations advancing science, healthcare, education, or community benefit, with emphasis on ATTR amyloidosis, AHP, and PH1.
Key Information: Only registered charitable organizations are eligible; individuals may not apply.
Description
Alnylam Pharmaceuticals offers Charitable Donations to registered charitable organizations to advance science, healthcare, education, and other authentic charitable purposes. The program prioritizes initiatives that align with Alnylam’s mission—improving patient health, elevating standards of care, and addressing unmet needs in healthcare and education—particularly in the areas of transthyretin-mediated amyloidosis (ATTR amyloidosis), acute hepatic porphyria (AHP), and primary hyperoxaluria type 1 (PH1). Donations are distinct from sponsorships and educational grants, as they do not require Alnylam to receive a tangible benefit and are not limited to educational programming. Supported activities must be compliant with all applicable legal and regulatory requirements.
